• Affiliate Assistant Professor, Global Health
  • Vice President, Corporate Development, Chembio Diagnostics Systems, Inc.
Phone Number: 
Select from the following:

Christine M. Rousseau, Ph.D. joined Chembio Diagnostics Systems, Inc. in July of 2018 as Vice President, Corporate Development. Prior to joining Chembio, Dr. Rousseau spent nine years at the Bill & Melinda Gates Foundation, most recently serving as Senior Program Officer, Global Health, Integrated Technology Solutions. While there, she directed over $250 million in assets for the development, commercialization, and scale-up of immune, molecular and cellular diagnostic technologies, including a significant role in HIV Self-Testing. In addition, Dr. Rousseau spent over ten years as a research scientist and faculty member at the University of Washington, with emphasis in the areas of HIV and HCV. Earlier in her career, she was a Senior Fellow at the Fred Hutchinson Cancer Research Center and HIV Director & Founding Board Member of the Sustainable Sciences Institute.

  • PhD (University of California (Berkeley))
  • MS (University of Washington)
  • BS (Ohio State University)
Country Affiliations 
  • Spanish
Health Topics 
  • Biodefense Infectious Diseases
  • Brain Injury
  • Burden of Disease
  • Cardiovascular Disease
  • Ebola
  • Hepatitis
  • Infectious Diseases
  • Infectious Diseases (other than STDs)
  • Leishmaniasis
  • Malaria
  • Mobile Health (mHealth)
  • Neglected Diseases, Tropical Medicine (incl. Parasites)
  • STDs (other than HIV)
  • Trop. Med (incl. Parasites)
  • Viruses